You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 4, January 28, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System, Other
 •Cardiovascular System
 •Radiologic Imaging
 •Renal Diseases
 •Renal Diseases, Other
 •Statistics and Research Methods
 •Angiology
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their randomized controlled trial, Dr Brar and colleagues1 found a lack of effectiveness of sodium bicarbonate in preventing CIN compared with saline. This study adds more controversy to the debate about what is the best strategy for CIN prevention. The authors discussed the results of 2 previous randomized trials that showed a remarkable benefit of sodium bicarbonate over saline for the prevention of CIN. However, the authors omitted a number of additional randomized studies evaluating the role of sodium bicarbonate in this setting that should have been taken into account in the discussion.

Recio-Mayoral et al2 compared the effect of an infusion of sodium bicarbonate plus N-acetylcysteine vs saline in a group of patients undergoing emergency percutaneous coronary interventions; the incidence of CIN in the former group was 1.8% compared with 21.8% in the group receiving saline (P < .001). In a similar population, Masuda . . . [Full Text of this Article]

Alberto Bouzas-Mosquera, MD
aboumos@canalejo.org

José M. Vázquez-Rodríguez, MD; Jesús Peteiro, MD, PhD
Department of Cardiology
Juan Canalejo Hospital
A Coruña, Spain



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium–Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial
Somjot S. Brar, Albert Yuh-Jer Shen, Michael B. Jorgensen, Adam Kotlewski, Vicken J. Aharonian, Natasha Desai, Michael Ree, Ahmed Ijaz Shah, and Raoul J. Burchette
JAMA. 2008;300(9):1038-1046.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
William Burgess, Gregory J. Merten, and Robert A. Rittase
JAMA. 2009;301(4):377.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Bradley D. Shy, Amit Gupta, and Robert S. Hoffman
JAMA. 2009;301(4):377-378.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Mehmet Kanbay, Benan Kasapoglu, and Ali Akcay
JAMA. 2009;301(4):378.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy—Reply
Somjot S. Brar, Albert Yuh-Jer Shen, and Michael B. Jorgensen
JAMA. 2009;301(4):379-380.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.